Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 2
1970 1
1975 1
1977 1
1979 2
1980 1
1981 2
1984 2
1985 5
1986 3
1987 4
1988 3
1989 3
1990 2
1991 4
1992 3
1993 4
1994 14
1995 10
1996 15
1997 16
1998 12
1999 15
2000 19
2001 23
2002 14
2003 18
2004 31
2005 37
2006 31
2007 29
2008 38
2009 28
2010 33
2011 30
2012 28
2013 32
2014 36
2015 49
2016 46
2017 38
2018 37
2019 37
2020 28
2021 31
2022 17
2023 21
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

766 results

Results by year

Filters applied: . Clear all
Page 1
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Watanabe J, Muro K, Shitara K, Yamazaki K, Shiozawa M, Ohori H, Takashima A, Yokota M, Makiyama A, Akazawa N, Ojima H, Yuasa Y, Miwa K, Yasui H, Oki E, Sato T, Naitoh T, Komatsu Y, Kato T, Hihara M, Soeda J, Misumi T, Yamamoto K, Akagi K, Ochiai A, Uetake H, Tsuchihara K, Yoshino T. Watanabe J, et al. Among authors: ochiai a. JAMA. 2023 Apr 18;329(15):1271-1282. doi: 10.1001/jama.2023.4428. JAMA. 2023. PMID: 37071094 Free PMC article. Clinical Trial.
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.
Shitara K, Muro K, Watanabe J, Yamazaki K, Ohori H, Shiozawa M, Takashima A, Yokota M, Makiyama A, Akazawa N, Ojima H, Yuasa Y, Miwa K, Yasui H, Oki E, Sato T, Naitoh T, Komatsu Y, Kato T, Mori I, Yamanaka K, Hihara M, Soeda J, Misumi T, Yamamoto K, Yamashita R, Akagi K, Ochiai A, Uetake H, Tsuchihara K, Yoshino T. Shitara K, et al. Among authors: ochiai a. Nat Med. 2024 Mar;30(3):730-739. doi: 10.1038/s41591-023-02791-w. Epub 2024 Feb 12. Nat Med. 2024. PMID: 38347302 Free PMC article.
Discovery of superconductivity in quasicrystal.
Kamiya K, Takeuchi T, Kabeya N, Wada N, Ishimasa T, Ochiai A, Deguchi K, Imura K, Sato NK. Kamiya K, et al. Among authors: ochiai a. Nat Commun. 2018 Jan 11;9(1):154. doi: 10.1038/s41467-017-02667-x. Nat Commun. 2018. PMID: 29323126 Free PMC article.
Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer.
Mitsunaga S, Ikeda M, Imaoka H, Sasaki M, Watanabe K, Sato A, Aoki K, Ochiai A, Makikawa M, Nishidate M, Yamaguchi K, Terao K, Sawada N, Fujitomo T, Fujii E, Kato A, Tsunoda H. Mitsunaga S, et al. Among authors: ochiai a. Cancer Sci. 2023 Oct;114(10):4006-4019. doi: 10.1111/cas.15929. Epub 2023 Aug 21. Cancer Sci. 2023. PMID: 37605479 Free PMC article.
Spiritual Experiences of Portuguese Women Who had a Water Birth.
da Costa Silveira de Camargo J, Dos Santos Oliveira Gama F, Ochiai AM, Araújo NM, Pinheiro LR, Néné M, Grande MCLR. da Costa Silveira de Camargo J, et al. Among authors: ochiai am. J Relig Health. 2023 Oct;62(5):3267-3284. doi: 10.1007/s10943-023-01826-3. Epub 2023 May 16. J Relig Health. 2023. PMID: 37193939
766 results